Cerenome Updates Investor Presentation on CNS Oncology Strategy
at www.tipranks.com (Fri, 2-Oct 7:58 AM)
Cerenome points to $1.55 million in Q3 CNSide gross billings as Medicare coverage progress targets 2027 start
Market Chameleon (Thu, 1-Oct 11:39 AM)
